NEW DELHI: Taking as a reference the benchmarks set by the World Health Organization and the US Food and Drug Administration, India’s drug regulator has said that it plans to approve the covid-19 vaccines that can provide immunity to at least 50% of the participants in phase 3 clinical trials. …
Read More »India May Approve COVID-19 Vaccines Showing 50% Efficacy In Clinical Trials
